The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Angiogenesis|Breast Cancer
Interventions: DRUG: endostar
Sponsor: Fujian Cancer Hospital